Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Takeda
Center for International Blood and Marrow Transplant Research
University of Washington
Memorial Sloan Kettering Cancer Center
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Center for International Blood and Marrow Transplant Research
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
University of Alabama at Birmingham
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Cogent Biosciences, Inc.
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Istituto Clinico Humanitas
City of Hope Medical Center
St. Petersburg State Pavlov Medical University
St. Petersburg State Pavlov Medical University
St. Petersburg State Pavlov Medical University
Washington University School of Medicine
University of Nebraska
Cellphire Therapeutics, Inc.
Rutgers, The State University of New Jersey
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Liege
Case Comprehensive Cancer Center
Stanford University
Fred Hutchinson Cancer Center